|
|
|
Insider
Information: |
Patrick Deval L |
Relationship: |
|
City: |
|
State: |
|
|
|
Insider
Summary: |
|
|
|
Companies Owned : |
7 |
|
Direct
Shares |
259,896 |
|
Indirect Shares
|
8,464 |
|
|
Direct
Value |
$4,145,880 |
|
|
Indirect Value
|
$31,968 |
|
|
Total
Shares |
268,360 |
|
|
Total
Value |
$4,177,849 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
Total
Filings :
|
1
|
0
|
Stock
price went up :
|
0
|
0
|
Stock
price went down : |
1
|
0
|
|
|
|
Gain/Loss Ratio : |
-1.0
|
0.0
|
Percentage
Gain/Loss : |
-75.4%
|
0.0%
|
|
|
|
|
|
|
Holdings
:
Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold |
|
Coca-Cola Co |
KO |
Executive Vice President |
2004-11-19 |
39,084 |
2004-11-19 |
464 |
Premium* |
|
Global Blood Therapeutics, Inc. |
GBT |
Director |
2022-10-05 |
0 |
2015-08-17 |
0 |
Premium* |
|
American Well Corp |
AMWL |
Director |
2023-06-22 |
169,892 |
2023-06-22 |
8,000 |
Premium* |
|
Twilio Inc |
TWLO |
Director |
2024-03-15 |
11,749 |
2021-01-13 |
0 |
Premium* |
|
Toast, Inc. |
TOST |
Director |
2024-02-22 |
35,889 |
2021-09-24 |
0 |
Premium* |
|
Cerevel Therapeutics Holdings, I... |
CERE |
Director |
2023-06-07 |
3,282 |
2022-09-12 |
0 |
Premium* |
|
GreenLight Biosciences Holdings,... |
GRNA |
|
2023-07-24 |
0 |
2023-07-24 |
0 |
Premium* |
|
|
|
|
|
|
|
|
|
|
Records found :
25 |
Free Registration Required For Full Results. Limit: 25
|
|
Download |
Page 1 of 1
|
Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
3m +/- |
|
|
Form |
TWLO |
Twilio Inc |
Director |
|
2021-01-13 |
4 |
A |
$0.00 |
$0 |
D/D |
1,267 |
1,267 |
0 |
- |
|
TWLO |
Twilio Inc |
Director |
|
2021-06-16 |
4 |
A |
$0.00 |
$0 |
D/D |
318 |
1,585 |
0 |
- |
|
TWLO |
Twilio Inc |
Director |
|
2021-09-15 |
4 |
A |
$0.00 |
$0 |
D/D |
210 |
1,795 |
0 |
- |
|
TWLO |
Twilio Inc |
Director |
|
2021-12-15 |
4 |
A |
$0.00 |
$0 |
D/D |
263 |
2,058 |
0 |
- |
|
TWLO |
Twilio Inc |
Director |
|
2022-03-15 |
4 |
A |
$0.00 |
$0 |
D/D |
431 |
2,489 |
0 |
- |
|
TWLO |
Twilio Inc |
Director |
|
2022-06-15 |
4 |
A |
$0.00 |
$0 |
D/D |
736 |
3,225 |
0 |
- |
|
TWLO |
Twilio Inc |
Director |
|
2022-09-15 |
4 |
A |
$0.00 |
$0 |
D/D |
1,008 |
4,233 |
0 |
- |
|
TWLO |
Twilio Inc |
Director |
|
2022-12-15 |
4 |
A |
$0.00 |
$0 |
D/D |
1,565 |
5,798 |
0 |
- |
|
TWLO |
Twilio Inc |
Director |
|
2023-03-15 |
4 |
A |
$0.00 |
$0 |
D/D |
1,101 |
6,899 |
0 |
- |
|
TWLO |
Twilio Inc |
Director |
|
2023-06-12 |
4 |
A |
$0.00 |
$0 |
D/D |
1,310 |
8,209 |
0 |
- |
|
TWLO |
Twilio Inc |
Director |
|
2023-09-15 |
4 |
A |
$0.00 |
$0 |
D/D |
1,192 |
9,401 |
0 |
- |
|
TWLO |
Twilio Inc |
Director |
|
2023-12-15 |
4 |
A |
$0.00 |
$0 |
D/D |
1,153 |
10,554 |
0 |
- |
|
TWLO |
Twilio Inc |
Director |
|
2024-03-15 |
4 |
A |
$0.00 |
$0 |
D/D |
1,195 |
11,749 |
0 |
- |
|
TOST |
Toast, Inc. |
Director |
|
2021-09-24 |
4 |
B |
$40.00 |
$66,680 |
D/D |
1,667 |
1,667 |
2.39 |
% |
|
TOST |
Toast, Inc. |
Director |
|
2022-02-22 |
4 |
OE |
$0.00 |
$0 |
D/D |
7,645 |
9,312 |
0 |
- |
|
TOST |
Toast, Inc. |
Director |
|
2023-02-22 |
4 |
OE |
$0.00 |
$0 |
D/D |
7,640 |
16,952 |
0 |
- |
|
TOST |
Toast, Inc. |
Director |
|
2023-06-02 |
4 |
OE |
$0.00 |
$0 |
D/D |
11,292 |
28,244 |
0 |
- |
|
TOST |
Toast, Inc. |
Director |
|
2024-02-22 |
4 |
OE |
$0.00 |
$0 |
D/D |
7,645 |
35,889 |
0 |
- |
|
GRNA |
GreenLight Biosciences Ho... |
See Remarks |
|
2023-07-24 |
4 |
D |
$0.00 |
$0 |
D/D |
(172,500) |
0 |
0 |
- |
|
GBT |
Global Blood Therapeutics... |
Director |
|
2015-08-17 |
4 |
B |
$20.00 |
$50,000 |
D/D |
2,500 |
2,500 |
2.39 |
- |
|
GBT |
Global Blood Therapeutics... |
Director |
|
2017-07-25 |
4 |
S |
$29.69 |
$803,204 |
D/D |
(27,053) |
0 |
0 |
- |
|
GBT |
Global Blood Therapeutics... |
Director |
|
2017-07-25 |
4 |
OE |
$3.40 |
$323,730 |
D/D |
27,053 |
27,053 |
0 |
- |
|
GBT |
Global Blood Therapeutics... |
Director |
|
2018-07-06 |
4 |
OE |
$3.40 |
$907,631 |
D/D |
42,379 |
42,379 |
0 |
- |
|
GBT |
Global Blood Therapeutics... |
Director |
|
2018-07-06 |
4 |
S |
$43.40 |
$1,839,283 |
D/D |
(42,379) |
0 |
0 |
- |
|
GBT |
Global Blood Therapeutics... |
Director |
|
2019-10-08 |
4 |
S |
$45.05 |
$241,333 |
D/D |
(5,357) |
0 |
0 |
- |
|
25 Records found
|
1
|
Page 1 of 1 |
|
Free Registration Required For Full Results. Limit: 25
|
|
|
Transaction Code Key: |
Ownership Code Key |
|
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
|
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
|
IO |
- Initital Ownership |
D |
- Disposed |
|
|
|
|
|
|